Jiangsu Alphamab Biopharmaceuticals Co., Ltd

This study is testing a new combination treatment called JSKN016 for people with advanced non-small cell lung cancer that has spread. The main goals are to see if the treatment is effective at shrinking tumors and safe for patients. It's an early-stage trial in China enrolling 28…

This is the first human study of an experimental cancer drug called JSKN022. Researchers want to find the safest dose and check for early signs that it might help control advanced solid tumors. The study will enroll 225 adults whose cancer has progressed despite standard treatmen…

This study is testing a new drug called JSKN003 against standard chemotherapy for people with advanced HER2-low breast cancer that has spread or returned. It is for adults whose cancer has worsened after trying 1 or 2 prior chemotherapy treatments. The goal is to see if JSKN003 c…

This study is testing whether a new drug called JSKN016, when combined with other cancer treatments, can help control advanced breast cancer that has spread or cannot be removed by surgery. It will involve 180 Chinese adults whose cancer does not respond to the HER2 protein. Rese…